The owner of the United States' largest pharmacy benefit manager (PBM) is declining to cover Gilead Sciences’ long-acting HIV ...

A new campaign from AbbVie highlights the “full selves” of people with conditions treated by the company’s therapies, in a ...

Johnson & Johnson will spend $2 billion over the next 10 years to operate a 160,000-square-foot manufacturing facility at ...

For the second time in the last three weeks, AbbVie has revealed successful results from a phase 3 study of Rinvoq as a treatment for the hair-loss disease alopecia areata (AA). | For the second time ...

Starting Sept. 1, the U.S. will impose a “Most Favored Nation” (MFN) tariff rate on generic pharmaceuticals sourced from the EU, including their ingredients and chemical precursors, according to a ...

Swoop and iSpot have joined forces to deliver insights into cross-platform ad exposures against specific audiences for healthcare and pharma marketers. | Swoop and iSpot have joined forces to deliver ...

Nucleus RadioPharma, a CDMO that specializes in the burgeoning field of radiopharmaceuticals, named former FDA Commissioner Dr. Stephen Hahn as its chief executive officer.